CAS 2049868-46-2

GSK'963

CAS: 2049868-46-2

Formel: C₁₄H₁₈N₂O

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 230.3055

Ref: IN-DA01FW4O

(S)-2,2-Dimethyl-1-(5-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)Propan-1-One

CAS: 2049868-46-2

(S)-2,2-Dimethyl-1-(5-Phenyl-4,5-Dihydro-1H-Pyrazol-1-Yl)Propan-1-One

Reinheit: 99%

Molekulargewicht: 230.31g/mol

Ref: 54-OR1024299

GSK963

CAS: 2049868-46-2

GSK963

Reinheit: ≥95%

Molekulargewicht: 230.31g/mol

Ref: 54-BUP04014

GSK963

CAS: 2049868-46-2

GSK963 (Racemate), a structurally distinct, potent and selective inhibitor of RIP1 kinase(IC50=29 nM).

Formel: C₁₄H₁₈N₂O

Reinheit: 98.00%

Farbe und Form: Solid

Molekulargewicht: 230.31

Ref: TM-T5054

GSK'963

CAS: 2049868-46-2

GSK'963 is a selective inhibitor, which is a pharmacological agent primarily targeting the receptor-interacting protein kinase 1 (RIP1). Originating from GlaxoSmithKline's research efforts, this inhibitor is a synthetic compound designed to interfere with specific biochemical pathways. GSK'963 operates by targeting the RIP1 kinase, a crucial component involved in necroptosis, a form of programmed cell death distinct from apoptosis.

Formel: C₁₄H₁₈N₂O

Reinheit: Min. 95%

Molekulargewicht: 230.31 g/mol

Ref: 3D-ZGD86846